Importantly, the blockade of neutrophils recruitment in the neonatal NOD mice using a CXCR2 antagonist dampens the diabetogenic T-cell response, the insulitis, and the incidence of diabetes. This evidence concerns the gene CXCR2 and diabetes mellitus.